<p>Starbucks launched its winter menu last week, featuring the return of the fan-favorite Pistachio Latte and the new Pistachio Cream Cold Brew. The Red Velvet Loaf returns to the bakery case to round out Starbucks winter menu.</p>
<p>The new handcrafted Starbucks <a href="https://www.starbucks.com/menu/product/2123702/iced" target="_blank" rel="noreferrer noopener">Pistachio Cream Cold Brew</a> features Starbucks Cold Brew sweetened with vanilla syrup, and is topped with silky pistachio cream cold foam and salted brown-buttery sprinkles. The Pistachio Cream Cold Brew builds on customers’ love of the Pistachio Latte and the popularity of cold coffee year-round.</p>
<div class="article__content">
<p>Returning for a third year is the fan-favorite <a href="https://www.starbucks.com/menu/product/2123404/hot?parent=/drinks/hot-coffees/lattes" target="_blank" rel="noreferrer noopener"><strong>Pistachio Latte</strong></a>, which made a splash when it launched in Winter 2021. Whether served hot, iced, or as a Frappuccino® blended beverage, the Pistachio Latte perfectly combines Starbucks signature espresso and milk with the cozy flavor of sweet pistachio and is finished with a salted brown butter topping.</p>
</div>
<div class="article__content">
<p>“Pistachio is the perfect flavor to follow the holidays and carry us through the winter season,” said Rosalyn Batingan on the Starbucks beverage team. “Its smooth and sweet profile delivers a feeling of warmth and coziness, even when served cold. With the Pistachio Cream Cold Brew, coffee lovers will savor the ultra-smooth combination of pistachio cream cold foam atop our cold brew. We are also delighted to welcome back the Pistachio Latte, which pairs our signature espresso, steamed milk, and flavors of sweet pistachio with top notes of brown butter.”</p>
<p>Starbucks winter menu food and beverages are available at Starbucks stores nationwide for a limited time, while supplies last.</p>
</div>

SAN JOSE -- Lumilens, a connectivity platform for AI infrastructure, has emerged from stealth, having…
SAN FRANCISCO – Expedition Therapeutics, a clinical-stage biotechnology company developing novel oral small molecule therapies…
SAN FRANCISCO -- Convex, a backend platform designed for reliability at scale, has landed a $57 million…
SAN FRANCISCO -- Aurelius Systems has closed a $40 million Series A funding round. The…
SANTA CLARA – Marvell Technology, a provider of data infrastructure semiconductor solutions, announced new innovations across its…
PALO ALTO -- Simile -- an AI-based simulation company -- has raised $200 million at…